| Identification | Back Directory | [Name]
TC-SP 14 | [CAS]
1257093-40-5 | [Synonyms]
TC-SP 14
1-[[3-Fluoro-4-[5-[(2-fluorophenyl)Methyl]-2-benzothiazolyl]phenyl]Methyl]-3-azetidinecarboxylic Acid
3-Azetidinecarboxylic acid, 1-[[3-fluoro-4-[5-[(2-fluorophenyl)methyl]-2-benzothiazolyl]phenyl]methyl]- | [Molecular Formula]
C25H20F2N2O2S | [MDL Number]
MFCD22683814 | [MOL File]
1257093-40-5.mol | [Molecular Weight]
450.5 |
| Chemical Properties | Back Directory | [Boiling point ]
608.1±65.0 °C(Predicted) | [density ]
1.396±0.06 g/cm3(Predicted) | [storage temp. ]
Desiccate at RT | [solubility ]
<22.52mg/ml in DMSO | [form ]
solid | [pka]
2.65±0.20(Predicted) | [color ]
Off-white |
| Hazard Information | Back Directory | [Uses]
1-[[3-Fluoro-4-[5-[(2-fluorophenyl)methyl]-2-benzothiazolyl]phenyl]methyl]-3-azetidinecarboxylic Acid is a potent Sphingosine-1-Phosphate Receptor 1 (S1P1) agonist with minimal activity at S1P3. It has been shown to attenuate DTH response to antigen challenge while significantly reducing blood lymphocyte counts. | [Biological Activity]
ec50: 0.042 μm for hs1p1tc-sp 14 is an agonist of sphingosine-1-phosphate receptor 1 (s1p1).studies have revealed that the lysophospholipid sphingosine-1-phosphate (s1p1) is a pleiotropic modulator of diverse cellular processes. such effects are reported to be mediated by the interactions of s1p with a set of paralogous g proteincoupled receptors, which are widely expressed in the immune, central nervous and cardiovascular systems. | [in vitro]
as a small lipophilic substituent proved equally effective to a larger substituent in reducing s1p3 activity, tc-sp 14 was screened. tc-sp 14 was found to be a potent s1p1 agonist (ec50 = 0.042 μm) with reduced activity for s1p3 (ec50 = 3.47 μm) [1]. | [in vivo]
in lewis rats, tc-sp 14 produced a dose-dependent reduction in circulating blood lymphocytes, which was consistent with s1p1 agonism. moreover, statistical significance was shown at a dose of 0.3 mg/kg, and the dose fo 3.0 mg/kg led to near maximal lymphopenia. tc-sp 14 was subsequently investigated in a dth antigen challenge model. results showed a statistically significant reduction in ear swelling at doses of 0.3 mg/kg and higher. in addition, reduced ear swelling was found to closely track circulating lymphocyte counts [1]. | [IC 50]
S1PR1: 0.042 μM (EC50); S1PR3: 3.47 μM (EC50) | [References]
[1] lanman ba,cee vj,cheruku sr et al. discovery of a potent, s1p3-sparing benzothiazole agonist of sphingosine-1-phosphate receptor 1 (s1p1). acs med chem lett.2010 nov 9;2(2):102-6. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
|